[HTML][HTML] BCL2A1: the underdog in the BCL2 family

M Vogler - Cell Death & Differentiation, 2012 - nature.com
Abstract B-cell lymphoma 2 (BCL2) proteins are important cell death regulators, whose main
function is to control the release of cytochrome c from mitochondria in the intrinsic apoptotic …

Inhibitors of BCL2A1/Bfl-1 protein: potential stock in cancer therapy

X Li, J Dou, Q You, Z Jiang - European Journal of Medicinal Chemistry, 2021 - Elsevier
The Bcl-2 family members rigorously regulate cell endogenous apoptosis, and targeting anti-
apoptotic members is a hot topic in design of anti-cancer drugs. At present, FDA and EMA …

Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load

DJ Eddins, J Yang, A Kosters, VD Giacalone… - Blood …, 2023 - ashpublications.org
Troubling disparities in COVID-19–associated mortality emerged early, with nearly 70% of
deaths confined to Black/African American (AA) patients in some areas. However, targeted …

[HTML][HTML] The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling

J Vier, M Groth, M Sochalska, S Kirschnek - Cell death & disease, 2016 - nature.com
Neutrophil granulocytes are innate effector cells of the first line of defense against pyogenic
bacteria. Neutrophil lifespan is short, is prolonged by pro-inflammatory stimuli, controls …

Last but not least: BFL-1 as an emerging target for anti-cancer therapies

G Wang, ST Diepstraten… - Biochemical Society …, 2022 - portlandpress.com
BFL-1 is an understudied pro-survival BCL-2 protein. The expression of BFL-1 is reported in
many cancers, but it is yet to be clarified whether high transcript expression also always …

[HTML][HTML] Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment

C Lee, S Lee, E Park, J Hong, DY Shin, JM Byun… - Genome Medicine, 2022 - Springer
Background Although anti-apoptotic proteins of the B-cell lymphoma-2 (BCL2) family have
been utilized as therapeutic targets in acute myeloid leukaemia (AML), their complicated …

CLEC5A (MDL-1) is a novel PU. 1 transcriptional target during myeloid differentiation

J Batliner, MM Mancarelli, M Jenal, VA Reddy… - Molecular …, 2011 - Elsevier
C-type lectin domain family 5, member A (CLEC5A), also known as myeloid DNAX activation
protein 12 (DAP12)-associating lectin-1 (MDL-1), is a cell surface receptor strongly …

[HTML][HTML] A1/Bfl-1 in leukocyte development and cell death

E Ottina, D Tischner, MJ Herold, A Villunger - Experimental cell research, 2012 - Elsevier
The function of the anti-apoptotic Bcl-2 family member Bcl2a1/Bfl-1/A1 is poorly understood
due to the lack of appropriate loss-of-function mouse models and redundant effects with …

LncRNA HORAS5 Promotes Taxane Resistance in Castration-Resistant Prostate Cancer via a BCL2A1-Dependent Mechanism

P Pucci, E Venalainen, I Alborelli, L Quagliata… - …, 2020 - Taylor & Francis
Background: Castration-resistant prostate cancer (CRPC) is an incurable malignancy. Long
noncoding RNAs (lncRNAs) play key roles in drug resistance. Materials & methods: LncRNA …

PU. 1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells

EA Federzoni, PJM Valk, BE Torbett… - Blood, The Journal …, 2012 - ashpublications.org
The transcription factor PU. 1 is a master regulator of myeloid differentiation and function. On
the other hand, only scarce information is available on PU. 1-regulated genes involved in …